Development
GSK plc
GSK
$41.30
$0.441.08%
NYSE
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.25B | 8.16B | 8.27B | 8.63B | 10.51B |
Total Receivables | 8.91B | 10.83B | 9.02B | 8.82B | 7.75B |
Inventory | 7.00B | 6.69B | 7.00B | 6.62B | 6.20B |
Prepaid Expenses | 452.18M | -- | -- | -- | 413.28M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 137.57M | 247.72M | 301.18M | 321.65M | 148.20M |
Total Current Assets | 23.75B | 25.92B | 24.59B | 24.40B | 25.02B |
|
|||||
Total Current Assets | 23.75B | 25.92B | 24.59B | 24.40B | 25.02B |
Net Property, Plant & Equipment | 12.68B | 11.54B | 11.84B | 11.65B | 11.59B |
Long-term Investments | 8.68B | 8.51B | 8.53B | 8.48B | 8.49B |
Goodwill | 8.68B | 8.51B | 8.53B | 8.48B | 8.49B |
Total Other Intangibles | 18.81B | 18.66B | 19.74B | 17.52B | 17.25B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 9.69B | 8.25B | 9.15B | 8.79B | 8.21B |
Total Assets | 75.16B | 74.27B | 75.56B | 72.49B | 72.47B |
|
|||||
Total Accounts Payable | 4.73B | 17.93B | 16.65B | 16.43B | 4.66B |
Total Accrued Expenses | 5.20B | -- | -- | -- | 4.77B |
Short-term Debt | 1.14B | 3.08B | 4.62B | 3.19B | 1.79B |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.45B | 2.83B | 2.91B | 2.08B | 2.97B |
Total Finance Division Other Current Liabilities | 13.32B | 3.48B | 3.92B | 3.90B | 13.29B |
Total Other Current Liabilities | 13.32B | 3.48B | 3.92B | 3.90B | 13.29B |
Total Current Liabilities | 26.84B | 27.32B | 28.09B | 25.60B | 27.48B |
|
|||||
Total Current Liabilities | 26.84B | 27.32B | 28.09B | 25.60B | 27.48B |
Long-Term Debt | 18.03B | 19.52B | 19.76B | 20.59B | 19.51B |
Short-term Debt | 1.14B | 3.08B | 4.62B | 3.19B | 1.79B |
Capital Leases | 1.34B | -- | -- | -- | 1.01B |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 12.66B | 12.02B | 12.25B | 12.30B | 12.30B |
Total Liabilities | 58.86B | 58.87B | 60.11B | 58.50B | 60.30B |
|
|||||
Common Stock & APIC | 6.11B | 5.86B | 6.10B | 5.93B | 5.77B |
Retained Earnings | 9.86B | 8.56B | 8.16B | 7.00B | 5.77B |
Treasury Stock & Other | 1.03B | 1.61B | 1.87B | 1.69B | 1.23B |
Total Common Equity | 17.00B | 16.03B | 16.13B | 14.62B | 12.77B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 17.00B | 16.03B | 16.13B | 14.62B | 12.77B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -703.11M | -627.24M | -676.06M | -628.46M | -604.86M |
Total Equity | 16.30B | 15.40B | 15.45B | 13.99B | 12.16B |
|